A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease.

Saved in:
Bibliographic Details
Title: A cross-sectional observational study of patients with sicca with salivary autoantibodies defines a potential new phenotype of Sjögren's disease.
Authors: Tsaliki M; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Cavett J; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Kurien BT; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Bruxvoort C; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Lewis VM; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Ice JA; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma., Dave D; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Departments of Medicine and Pathology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma., Khosravani S; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Grundahl K; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Genes and Human Diseases Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Lessard CJ; Department of Pathology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma; Genes and Human Diseases Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Rasmussen A; Genes and Human Diseases Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Sivils KL; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Farris AD; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Koelsch KA; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma., Scofield RH; Arthritis and Clinical Immunology Research Program, Oklahoma Medical Research Foundation, Oklahoma City, Oklahoma; Oklahoma City US Department of Veterans Affairs Medical Center, Oklahoma City, Oklahoma; Departments of Medicine and Pathology, College of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma. Electronic address: hal-scofield@omrf.ouhsc.edu.
Source: Annals of the rheumatic diseases [Ann Rheum Dis] 2025 Aug; Vol. 84 (8), pp. 1354-1362. Date of Electronic Publication: 2025 May 03.
Publication Type: Journal Article; Observational Study
Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 0372355 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1468-2060 (Electronic) Linking ISSN: 00034967 NLM ISO Abbreviation: Ann Rheum Dis Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1468-2060
DOI:10.1016/j.ard.2025.03.012